Unexpected recalcitrant course of drug-induced erythema multiforme-like eruption and interstitial pneumonia sequentially occurring after nivolumab therapy.
Nomura, Hisashi
Unexpected recalcitrant course of drug-induced erythema multiforme-like eruption and interstitial pneumonia sequentially occurring after nivolumab therapy. [electronic resource] - The Journal of dermatology Jul 2017 - 818-821 p. digital
Publication Type: Case Reports; Journal Article
1346-8138
10.1111/1346-8138.13810 doi
Adult
Antibodies, Monoclonal--therapeutic use
Antineoplastic Agents, Immunological--therapeutic use
Biopsy
CTLA-4 Antigen--antagonists & inhibitors
Chemotherapy, Adjuvant--adverse effects
Drug Eruptions--diagnosis
Drug Resistance
Erythema Multiforme--chemically induced
Fever--chemically induced
Glucocorticoids--pharmacology
Humans
Indoles--therapeutic use
Ipilimumab
Lung Diseases, Interstitial--drug therapy
Lymphatic Metastasis
Male
Melanoma--genetics
Mutation
Neoplasm Recurrence, Local--pathology
Nivolumab
Parotid Neoplasms--drug therapy
Programmed Cell Death 1 Receptor--antagonists & inhibitors
Proto-Oncogene Proteins B-raf--antagonists & inhibitors
Pulse Therapy, Drug
Skin Neoplasms--genetics
Sulfonamides--therapeutic use
Tomography, X-Ray Computed
Trimethoprim, Sulfamethoxazole Drug Combination--therapeutic use
Vemurafenib
Withholding Treatment
Unexpected recalcitrant course of drug-induced erythema multiforme-like eruption and interstitial pneumonia sequentially occurring after nivolumab therapy. [electronic resource] - The Journal of dermatology Jul 2017 - 818-821 p. digital
Publication Type: Case Reports; Journal Article
1346-8138
10.1111/1346-8138.13810 doi
Adult
Antibodies, Monoclonal--therapeutic use
Antineoplastic Agents, Immunological--therapeutic use
Biopsy
CTLA-4 Antigen--antagonists & inhibitors
Chemotherapy, Adjuvant--adverse effects
Drug Eruptions--diagnosis
Drug Resistance
Erythema Multiforme--chemically induced
Fever--chemically induced
Glucocorticoids--pharmacology
Humans
Indoles--therapeutic use
Ipilimumab
Lung Diseases, Interstitial--drug therapy
Lymphatic Metastasis
Male
Melanoma--genetics
Mutation
Neoplasm Recurrence, Local--pathology
Nivolumab
Parotid Neoplasms--drug therapy
Programmed Cell Death 1 Receptor--antagonists & inhibitors
Proto-Oncogene Proteins B-raf--antagonists & inhibitors
Pulse Therapy, Drug
Skin Neoplasms--genetics
Sulfonamides--therapeutic use
Tomography, X-Ray Computed
Trimethoprim, Sulfamethoxazole Drug Combination--therapeutic use
Vemurafenib
Withholding Treatment